In a patient who had a total thyroidectomy and radioactive iodine treatment six years ago for thyroid cancer, with negative lymph‑node mapping, normal abdominal CT, negative thyroid antibodies, low‑normal TSH, normal free T4, and a mildly elevated but decreasing thyroglobulin level, is there evidence of recurrent disease and what follow‑up is recommended?

Thyroglobulin Monitoring After Thyroidectomy and RAI

Based on your declining thyroglobulin trend (from 2.7 to 1.1 ng/mL), negative imaging, and negative antibodies, you have an "indeterminate response" that does NOT indicate recurrent disease and requires continued surveillance every 6-12 months without additional treatment at this time. 1

Understanding Your Current Status

Your clinical picture shows:

• Thyroglobulin levels: Mildly elevated (0.9-2.7 ng/mL) but decreasing over time
• TSH: 0.877 mIU/L (low-normal, appropriate for surveillance)
• Thyroid antibodies: Negative (rules out assay interference)
• Imaging: All negative (lymph node mapping, CT abdomen)
• Time since treatment: 6 years post-thyroidectomy and RAI

Response Classification

According to ESMO 2019 guidelines, you fall into the "indeterminate response" category because you have:

• Negative imaging findings
• Detectable but low thyroglobulin (between 0.2-1 ng/mL on most recent measurements)
• No rising trend (actually declining)

1

This is distinctly different from "biochemical incomplete response" which requires Tg >1 ng/mL or stimulated Tg >10 ng/mL with rising values. 1

Why This is NOT Recurrent Disease

The critical factor is the trend: Your thyroglobulin is decreasing (2.7→1.5→0.9→0.9→1.1 ng/mL), not rising. Rising Tg is highly suspicious for persistent/recurrent disease, but stable or declining low-level Tg in the setting of negative imaging typically represents residual microscopic normal thyroid tissue, not cancer. 1

After total thyroidectomy with RAI, almost 60% of patients will have basal serum Tg levels >0.2 ng/mL, which simply indicates small amounts of residual thyroid tissue. 1 Your levels are consistent with this benign scenario.

Recommended Management Algorithm

TSH Target: Maintain TSH 0.5-2 mIU/L (you're currently at 0.877, which is perfect) 1

Surveillance Schedule:

• Thyroglobulin and TgAb: Every 6-12 months 1
• Neck ultrasound: Every 6-12 months initially, then can extend to every 12-24 months if stable 1

When to Escalate Concern:

• Thyroglobulin doubling time <1 year (you don't have this—yours is declining) 1
• Absolute Tg rising above 5 ng/mL with similar TSH levels 1
• New structural findings on ultrasound
• Development of thyroglobulin antibodies

What You DON'T Need

No additional RAI therapy: You have negative imaging and declining Tg—there's no target to treat 1

No FDG-PET scan: This is only indicated if you develop a rising Tg trend 1

No stimulated Tg testing: With your negative imaging and low basal Tg, stimulated testing adds little value and is optional in your risk category 1

Critical Pitfalls to Avoid

1. Don't over-interpret single Tg values: The slight increase from 0.9 to 1.1 ng/mL is not clinically significant—focus on the overall declining trend 1

2. Ensure same assay for serial measurements: Tg should ideally be measured with the same laboratory assay to minimize variability 1

3. Always check TgAb: You're doing this correctly—negative antibodies confirm your Tg measurements are reliable 1

4. Don't pursue aggressive imaging for low stable Tg: Your negative CT and lymph node mapping already demonstrate no structural disease 1

Long-term Outlook

Patients with indeterminate response and declining or stable low-level Tg have excellent outcomes. The vast majority never develop structural recurrence. Your 6-year follow-up with declining Tg is particularly reassuring. Continue surveillance as outlined, but you can be confident this does not represent active disease requiring intervention. 1, 2, 3